SJANDD

Scope Of The Journal

SPER Journal of Advances in Novel Drug Delivery [SJANDD] aims to explore the knowledge of pharmacy professionals and cater the need of research and development activities of both academia and Industries. Further, also aimed to bridge the gap between theoretical aspects of drug delivery concepts and practical clinical studies to make sure of the novel drug delivery system usefulness in health care system. The Journal having scope for researchers engaged in drug delivery field to utilize the scientific contents in a rightful way.
SPER Journal of Advances in Novel Drug Delivery [SJANDD], a broad-based journal was founded on two key tenets:
To publish the most exciting researches with respect to the subjects of Pharmaceutical science. Secondly, to provide a rapid turn-around time possible
for reviewing and publishing, and to disseminate the articles freely for research, teaching and
reference purposes.
Our objective is to inform authors of the decision on their manuscript as early as possible. Following acceptance, a paper will normally be published in the next available issue.
SPER Journal of Advances in Novel Drug Delivery [SJANDD], is using online manuscript submission, review and tracking system for quality and quick review processing. Review processing is performed by the editorial board members of SJANDD, outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript.
An Open Access Publication is one that meets the following two conditions:
The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).